Summary The effects of the major human serum bile acid, glycochenodeoxycholic acid (GCDC), as well as unconjugated chenodeoxycholic acid (CDC), on the MCF-7 human breast cancer cell line have been studied in vitro under oestrogen and bile acid deprived culture conditions. GCDC increased the growth of the breast cancer cells over the range 10-300 jiM. At concentrations in excess of the bile acid binding capacity of the medium cell growth was prevented. In contrast 10 jiM CDC tended to reduce cell growth. Oestrogen (ER) and progesterone (PgR) receptors, pS2 and total cathepsin D were quantified by monoclonal antibody based immunoassays. Ten to 100 jiM GCDC and 10 jIM CDC down-regulated ER protein and this was accompanied by induction of the oestrogen-regulated proteins PgR, pS2 and possibly cathepsin D, including increased secretion of the latter two proteins into the culture medium. All these changes were quantitatively similar to those observed with 10 nm oestradiol. The bile acid effects on ER and PgR were not due to interference with the assay procedures. Cells incubated with 50 jIM GCDC or 10 jIM CDC had higher pmolar concentrations of the bile acids than controls. This study suggests that naturally occurring bile acids influence the growth and steroid receptor function of human breast cancer cells.
Although bile acids have been considered to play a role in the aetiology and/or growth of colorectal cancer (Hill, 1983) little attention has been paid to the possible activity of these steroidal compounds in breast cancer. Epidemiological studies have demonstrated that rates of breast and colon cancers are highly correlated with each other and with high fat and animal protein diets (Drasar & Irving, 1973) . In the few studies published the data suggest that women with breast cancer may have differences in the faecal excretion of bile acids compared with controls; decreased (Murray et al., 1980) and increased (Papatestas et al., 1982) faecal concentrations, and altered ratio of individual bile acids (Owen et al., 1986) have been reported. Long-term follow-up of women undergoing cholecystectomy has revealed an increased risk of breast cancer which increased with time after operation (Gudmundsson et al., 1989) . In contrast, by reducing the enterohepatic circulation of oestrogens and bile acids, the high consumption of fibre and fermented milk products, particularly in combination with low fat and animal protein intake, may provide some protection against breast cancer (Adlercreutz, 1990) . These findings, while by no means conclusive, imply that breast cancer patients are subject to changes in circulating levels of bile acids and consequently the potential exposure of breast tissue and/or tumour. In support of the latter possibility is our observation, now confirmed by others, that breast cyst fluid contains very high levels of bile acids, notably the glycine conjugates of chenodeoxycholic (CDC), deoxycholic and cholic acids (Baker et al., 1986 and 1988a; Raju et al., 1990 ).
Bile acids have been shown to produce DNA changes in murine lymphoblastoma cells and in yeast cells (Ferguson & Parry, 1984; Kulkarni et al., 1980) . Several bile acids are mutagenic at non-toxic doses (Watabe & Bernstein, 1985) , and have co-carcinogenic activity on a murine fibroblast cell line (Kawasumi et al., 1988) .
The action of bile acids on human breast cancer cells has not previously been studied apart from our own preliminary reports (Baker et al., 1988b; Wilton et al., 1990 (Baker et al., 1987) . During tamoxifen treatment of elderly breast cancer patients the serum GCDC concentration is reduced while there is some increase in the unconjugated bile acid fraction containing CDC . Perhaps complimentary to this latter observation are the lower levels of unconjugated bile acids (cholic, CDC & deoxycholic) in the serum of women with oestrogen receptor (ER) rich tumours and in healthy women taking oral contraceptive steroids continuously for over 6 years (Baker et al., 1987) .
We have therefore investigated the effects of GCDC and CDC on the human breast cancer cell line MCF-7, with particular emphasis on changes in ER and the oestrogenregulated proteins progesterone receptor (PgR), pS2 and cathepsin D (Brown et al., 1984; Capony et al., 1989; Horwitz et al., 1978; Johnson et al., 1989; Kida et al., 1989; May et al., 1989; May & Westley, 1988 (GC) or chenodeoxycholic acid (CDC) containing 100 nCi of '4C-labelled GC or CDC respectively in a total volume of 1.0 ml of 10 mM phosphate buffer pH 7.4 for 3 h at 37°C with repeated mixing. Three 40 1tl aliquots of the incubate were taken for counting (total radioactivity) and 800 t l I was passed through a YMT ultrafiltration membrane in a MPS-1 unit (Amicon, Stonehouse, England) by centrifugation at 1,000 g for 10 min. The resulting ultrafiltrate (3 x 40 pl) was added to 10 ml Scintran Cocktail T (BDH) and the radioactivity counted (free or non-protein bound activity). The amount of bound radioactivity was calculated and used as an expression of bile acid binding capacity.
Cell culture procedures Cells were grown at 37°C with 5% CO2 in air and were maintained prior to experimentation in DME:Ham's F-10 (1:1) or DME media, both with phenol red, and containing 10% or 5% FCS and supplemented with glutamine (2mM), penicillin (50 IU ml1), streptomycin (50 fig ml-') and usually 1% non-essential amino acids (NEAA) and insulin (1ltg ml'). For experimentation cells growing in log-phase were transferred to phenol red free DME:Ham's F-12 (1:1) medium containing 5% DCC-FCS and the above supplements (experimental medium) in 24 Coulter counter or with a haemocytometer. In later studies cells were counted as nuclei using the method of Butler et al.,
1981.
Cell homogenisation 'Cytosol' preparation Harvested cells were washed several times in PBS, suspended in 10 mM Tris buffer pH 7.4 containing 1.0 mM EDTA, 15% glycerol and 0.25 mM dithiothreitol (DTT) and homogenised on ice with an Ultra-Turrax (model T 18/10, Sartorius, England) for 3 x 10 s at near maximum speed. The supernatant obtained after centrifugation at 600 g for 10 min and 5,000 g for 30 min at 4°C was used as a 'cytosol' preparation for immediate assay of steroid receptors. Cytosol prepared from this supernatant by centrifugation at 100,000 g in a Beckman model L2-65B ultracentrifuge was shown to give very similar levels of ER by EIA (see below) as the lower speed preparation (99 ± 15%, n = 4).
'Whole cell' extraction For the later studies in which ER and PgR were assayed in 'whole cell' extracts, harvested cells were washed several times in PBS, suspended in 10 mM HEPES buffer pH 7.4, containing 0.4 M KCI, 5 mM sodium molybdate, 1.5 mM EDTA, 10% glycerol and 0.5 mM DTT and homogenised as above. The supernatant after centrifugation at 2,000 g for 10 min and 5,000 g for 30 min at 4°C was used for immediate assay of ER and PgR. Aliquots of the extract as well as culture medium were stored at -40°C for other assays.
Steroid receptor assays ER and PgR were determined in duplicate in 'cytosol' and 'whole cell' preparations with the enzyme immunoassays (EIA) supplied by Abbott Diagnostics (Maidenhead, England) . Both the quality control (QC) material supplied with the kits and an external QC supplied by the EORTC were assayed with each batch of cell samples. Precision (CV%) of the assays was as follows: ER < 100 fmol mg-', 4.8% (n = 27), ER> I00 fmol mg', 5.0% (n = 64), PgR <O00 fmol mg-', 6.0% (n = 23), PgR= 100-500fmolmg', 2.3% (n = 32), PgR> 500 fmol mg-1, 8.6% (n = 30). pS2, Cathepsin D and GCDC assays The oestrogen-regulated proteins pS2 and cathepsin D (52 kd pro-cathepsin D plus the active enzyme) were determined with the two site immunoradiometric assays (ELSA-PS2 and ELSA-CATH-D) supplied by CIS (UK) Ltd. (High Wycombe, England). Assays were performed in duplicate on stored 'whole cell' extracts or culture medium diluted appropriately with the diluent provided in the kits. The high KCI concentration of the homogenisation buffer had no effect on the quantification of either protein (personal observation and information from CIS). The CV for the pS2 assay was 5.4% (n = 50) over the range 29-2,006 pg ml-' diluted sample. For the cathepsin D assay the CV was 5.4% (n = 50) for values < 1,000 fmol ml-' diluted sample and 10.7% (n = 50) for values > 1,000 fmol ml1-I diluted sample.
GCDC and CDC in 'whole cell' extracts were quantified with the same radioimmunoassay supplied by Farmos Diagnostica (Pharmacia Ltd, Milton Keynes, England) using the kit procedure for serum which involves extraction into 95% ethanol prior to assay. The CV was 8.6% (n = 29). This assay was also performed on whole cells by dissolving the washed (3 x) intact cell pellet in 1 ml 5% NaOH at 80°C for 1.5 h, diluting with 9 ml of water and extracting the bile acids into methanol on a 100 mg Bondelut C18 solid phase cartridge (Jones Chromatography, Hengoed, Wales). The dried methanol extract was then extracted into 95% ethanol ready for assay.
Protein assay Protein levels in cell preparations were determined using the Bio-Rad protein assay with bovine serum albumin as standard.
Statistical analysis
Precision of an assay is expressed as the coefficient of variation (CV%) obtained from series of n duplicates. Results are usually expressed as mean ± s.d. Statistical analysis was performed by analysis of variance (AOV) with the Dunnett test for multiple comparisons with control, or by paired t-test; the 5% level was considered to indicate a signficant difference.
Results
Bile acid binding capacity of DCC-FCS The bile acid binding capacity of DCC-FCS in Jmol ml-' undiluted serum was 2.4 ± 0.4 (n = 2) and 11.2 ± 0.3 (n = 4) for GC and CDC respectively. From these values, the concentration of protein-bound bile acid in culture medium containing 5% DCC-FCS would be 118 ± 20 gM for GC and 558 ± 16 .LM for CDC. Since bile acid binding to serum albumin is a characteristic of the degree of hydroxylation of the steroid nucleus rather than glycine conjugation (Lawrence et al., 1980) , these data suggest that medium containing 5% DCC-FCS would have a GCDC protein binding capacity of approximately 500 JIM.
Cell growth Early studies were performed using MCF-7(REL) cells. The effect of increasing concentration of GCDC on cell growth is illustrated in Figure 1 . Growth stimulation in this and other similar experiments was clearly seen at concentrations of GCDC between 10 and 300 JIM, although above 100 JIM growth stimulation was not maintained after 8 days. Above 500 JIM GCDC was cytostatic, possibly because the protein binding capacity of the medium was exceeded. At high concentrations (1 mM) GCDC was cytotoxic (data not shown).
Optimum growth stimulation appeared to occur at 100 JIM GCDC and this produced significantly increased cell numbers after 7 to 10 days of culture (25.0 ± 8.7 104 cells cm-2; control = 11.9 ± 4.0, P < 0.005, n = 7), and a significant decrease in doubling time (1.8 ± 0.4 days; control = 2.6 + 0.4, P <0.02, n = 4). This effect did not seem to depend on 'conditioning' of the cells in oestrogen and bile acid depleted medium for 10 days prior to addition of GCDC. Preliminary studies with a series of glycine conjugated and unconjugated bile acids at 100 JIM suggests that at this concentration, glycoursodeoxycholic, ursodeoxycholic and cholic acids have little effect on cell growth, while glycolithocholic, lithocholic, deoxycholic and CDC are cytotoxic, and glycine conjugates of cholic, deoxycholic and CDC all stimulate cell growth. Pre-conditioning cells in oestrogen and bile acid depleted medium prior to experimentation was routinely performed in subsequent studies with MCF-7 (AEW) cells. Although this was done most commonly for 14 days the effects on growth and steroid receptors seen with shorter times (2 or 7 days) were very similar and therefore results have been combined. Lower concentrations of bile acids were used in these experiments in an attempt to study more physiological levels. In these experiments (n = 4-5) a reduction in mean doubling time was seen for 10 nM oestradiol (1.8 ± 0.4 days), 10 JIM GCDC (1.6 ± 0.2) and 50 JIM GCDC (1.5 ± 0.1) compared with control (1.9 ± 0.2). These differences were not significant on multiple comparisons analysis (Dunnett test), although the effect of 50 JLM GCDC was significant (P <0.02) when compared with controls by paired t-test. In three of four experiments 10 J1M CDC reduced cell growth giving a doubling time of 2.2 ± 0.5 days. The MCF-7(AEW) cells used in this study grew well in the oestrogen and bile acid depleted medium containing 1 jIg ml-' human insulin, and the growth stimulation by 10 nM oestradiol was modest. In a separate series of experiments cell doubling times were greatly reduced from control (3.0 ± 0.2 days; n = 5) by 1 lIM tamoxifen (5.8 ± 0.2) and 4-hydroxytamoxifen (6.1 ± 0.3), while tamoxifen at 0.1 JIM had little or no effect on cell proliferation.
Steroid receptors, pS2 and cathepsin D Since concentrations of GCDC> 100 JIM eventually resulted in reduced cell growth (Figure 1 ) the effects of the bile acid on these proteins were studied at 10-100 JM. Cells were harvested after 7 days culture without or with 10nM oestradiol or bile acids. ER levels in 'cytosol' of MCF-7(REL) cells were reduced by 10 nM oestradiol and 100 JM GCDC as shown in Table I . In later experiments MCF-7(AEW) cells were grown in oestrogen and bile acid depleted medium for 2 to 14 days prior to addition of lower, and more physiological, levels of GCDC and CDC, and a similar degree of down-regulation of ER in 'whole cell' extracts was observed (Figure 2) .
The down-regulation of ER by bile acids and oestradiol was accompanied by significant induction of PgR and pS2 by these agents in the same series of experiments (Figures 3 and  4) . Furthermore, the substantial secretion of the latter protein into the culture medium observed in controls was greatly increased by both bile acids (Table II) . Although there appeared to be some increase in the mean levels of total cathepsin D (pmol mg-1) in these 'whole cell' extracts in response to oestradiol (28 ± 10, n = 5), 10 JIM GCDC (29 +14, n =4), 50JM GCDC (28 ± 19, n = 6) and CDC (30 ± 9, n = 4), comparisons with controls (22 ± 13, n = 6) did not reach significance. However, in the two experiments in which cathepsin D was assayed in the medium 10 and 50 JIM GCDC appeared to approximately double the secretion of the protein (Table II) .
Tamoxifen and 4-hydroxytamoxifen at 1 JlM increased ER in 'whole cell' extracts relative to oestradiol stimulation (327 ± 65%, n = 3; and 403 ± 57%, n = 2, respectively) and decreased PgR (15 ± 3% and 13 ± 3%, respectively Figure 2 ER levels (fmol mg-' protein) in MCF-7(AEW) cells grown in the presence of oestradiol, GCDC or CDC. Cells were grown for 2 (one experiment), 7 (one experiment) or 14 (four experiments) days in experimental medium before transfer to 75 cm2 flasks con'taining 15 ml of medium. After 24 h the medium was replaced with fresh medium without (CTRL = Control) or with 10 nM oestradiol (E2), 1IOlM GCDC (GCDC10), 5011M GCDC (GCDC50) or 1OJLM CDC (CDC1O). Medium was changed every 2-3 days. After 7 days (late log-phase) cells were harvested, homogenised to prepare a 'whole cell' extract and assayed as described under Methods. Results are expressed as mean (columns) and s.d. (error bars) for the number of experiments shown at the foot of each column. The P values above the columns are for analysis using the Dunnett test for multiple comparisons with CTRL (OAV gave P 0.011). (25 ± 13). At 1 !LM tamoxifen also increased cellular cathepsin D relative to control (204 ± 97%, n = 2) as well as the amount secreted into the medium (253 ± 16%, n = 2). Interestingly, 0.1 LM ICI 164384 increased cellular levels of cathepsin D in two of three experiments but had little effect on secretion of the proteinase into the culture medium. Very low levels of secreted pS2 were obtained when cells were grown for 6 days in medium without FCS (18 ± 9% of control, n = 2). Antioestrogen effects on pS2 were not studied. decrease was seen at 50 and 100 f4M GCDC. These concentrations are far in excess of the levels of bile acids detected in cell extracts (see below). Over the concentration range 5-100 AM GCDC the recovery of the added bile acid from the cytosol was 89 ± 8%.
GCDC and CDC in 'whole cell' extracts and whole cells The 'whole cell' extracts in which oestrogen receptor and regulated proteins were measured were assayed for GCDC/ CDC content by RIA. Control cells contained low levels of the bile acids (2.5 ± 2.9 pmol 106 cells) consistent with the residual concentration of bile acids in the medium (24 nM For experiments 1 and 2 (both proteins) cells were grown as described in the legend to Figure 2 (7 or 14-day pre-conditioning) and 72 h medium was collected after 7 days of culture when the cells were harvested. For experiments 3 and 4 (pS2 only) 1-3 x 105 cells, pre-conditioned for 7 days, were plated out and grown in 1 ml of experimental medium in 35 mm dishes and 48 h medium after 6 days culture was assayed for pS2. (aThe effect of E2 on pS2 and cathepsin D secretion was only studied in one experiment).
While extracts of cells incubated with 10 gM GCDC had similar levels (3.8 ± 3.0), cells incubated with 50 JAM GCDC (15.3+7.6, P<0.01, Dunnett test) or 1O1M CDC (11.4 ± 3.6, P <0.05) contained significantly higher amounts of bile acid. These latter results have been confirmed in separate experiments in which whole cells, harvested every 2 days and processed as described above, had increasingly higher levels of GCDC or CDC compared with controls; this indicates that the cell-associated bile acid is not due to simple cell adherence or residual medium. At 8 days the bile acid levels of cells incubated with 10 JAM CDC and 50 gM GCDC were 17.0 ± 2.2 and 34.2 ± 1.4 pmol 10-6 cells (n = 2) respectively compared with 1.8 ± 0.6 in controls.
Discussion
The most significant aspect of the present study is the demonstration that GCDC and CDC appear to exert an oestrogen-like effect on MCF-7 cells by down-regulating ER levels and inducing the oestrogen regulated proteins PgR and pS2, and possibly cathepsin D. The down-regulation of ER was observed for both 'cytosol' and 'whole cell' levels of the receptor which is localised to the nucleus in vivo (King & Greene, 1984) from where it can be extracted into the soluble supernatant by homogenisation with buffer containing 0.4 M KCI (Saceda et al., 1988) . Nevertheless, the decrease in 'cytosolic' ER by 100 JAM GCDC in early experiments was similar to that seen in 'whole cell' extracts of cells exposed to 10-50 JAM GCDC and 1O JM CDC. The lower levels of bile acids are within the range of post-prandial serum concentrations (Beckett et al., 1981) . The use of a monoclonal antibody enzyme immunoassay (King & Greene, 1984) provided a very sensitive and precise method of measuring receptor protein, and the levels of ER in control cells and cells treated with oestradiol observed here were very similar to those in a previous study using the same assay kit (Saceda et al., 1988) . Furthermore, the decrease in ER protein after 7 days oestradiol treatment agrees well with the downregulation of ER mRNA after 2 days reported by others (Berkenstam et al., 1989; Saceda et al., 1988 ). The present study shows that the degree of down-regulation of ER by 10-1I100M GCDC and 1I0 JM CDC was very similar to that seen with 10 nM oestradiol.
The accompanying induction of PgR, pS2 and possibly also cathepsin D by the two bile acids was also similar to that seen with 10 nM oestradiol. The degree of oestradiol induction of PgR mRNA and protein is reported to be 2-10-and 3-20-fold respectively Katzenellenbogen et al., 1987; Nardulli et al., 1988; Wei et al., 1988) , which is consistent with our data for oestradiol and bile acids, although larger increases have been observed Read et al., 1988) . The induction of PgR by oestrogen appears to be due to changes at the transcriptional, or possibly post-transcriptional, level, rather than alteration of protein degradation (Read et al., 1988; Nardulli et al., 1988; Wei et al., 1988) , but whether this applies to bile acids cannot be concluded from the present study. The effect of progestins on bile acid-induced PgR levels might provide a useful insight into this mechanism (Wei et al., 1988) . ER and PgR response to 0.1, 1 JAM tamoxifen (oestrogenic), 1 lJM tamoxifen or 4-hydroxytamoxifen (antioestrogenic) and ICI 164384 are consistent with previous reports of oestrogenresponsive MCF-7 cells Johnson et al., 1989; May et al., 1989; Read et al., 1988) .
The secreted protein pS2/pNR2 appears to be under primary oestrogen control in breast tumours and cell lines, but is also expressed by several epithelial tumours as well as some normal tissues (Brown et al., 1984; Cavailles et al., 1989; Henry et al., 1991; May & Westley, 1988) . In addition pS2, via activation of its enhancer element, is also induced by insulin, IGF-I, bFGF, EGF, increased intracellular cAMP, stimulation of protein kinase C (PKC) by phorbol esters and some oncogene products Nunez et al., 1989 ). Many of these factors are known to mediate the mitogenic activity of oestrogens, but the pS2 protein itself is not a mitogen and its function is still unknown (Kida et al., 1989) . As well as inducing pS2, activation of PKC can result in increased PgR levels (Sumida & Pasqualini, 1990 (Capony et al., 1989; May & Westley, 1988) . It is induced by many of the same factors that stimulate pS2 but not increased cAMP or PKC activation . The MCF-7 cells used here, although responding poorly to oes-tradiol, exhibited increased levels of cathepsin D in response to tamoxifen as reported previously .
There is some evidence that bile acids, including CDC and deoxycholic acid (DC), can influence PKC activity, the direction of the effect being dependent on the concentrations of calcium (Ca2") and phosphatidylserine (Fitzer et al., 1987) .
Activation of PKC is involved in the DC-stimulated proliferation of colonic epithelium, the bile acid probably acting indirectly by stimulating polyphosphoinositide turnover (Craven et al., 1987) . Since at physiological concentrations and pH CDC and DC, and their glycine conjugates, exhibit high binding affinities for Ca2" (Gleeson et al., 1990) , and l1M concentrations of CDC and its monohydroxy metabolites can release Ca2+ from intracellular stores and increase Ca2+ uptake in non-hepatic cells (Coquil et al., 1991; Oelberg et al., 1990) , bile acid interaction with Ca2" may represent a potential mechanism for modulation of PKC activation.
Hypothetically, the observed effects of 1O-1I00 LM GCDC although human insulin at 1 tig ml-' was always present in the experimental medium. The growth characteristics of the MCF-7 cell line does appear to depend on the particular sub-clone used by different workers, some of which are not totally oestrogen-dependent (Darbre & Daly, 1989; Katzenellenbogen et al., 1987) . Indeed the doubling time for cells grown in 5% DCC-FCS and without phenol red for 1 week observed in the present study is very similar to that reported previously (Katzenellenbogen et al., 1987) . A steroid memory effect may have been a contributory factor to the basal cell growth (Darbre & Daly, 1989) , although differences in response between cells previously grown in the absence of oestrogens for 14 days or for shorter periods were not seen. The inhibition of cell proliferation by 1.OAM tamoxifen or 4-hydroxytamoxifen, and the lack of stimulatory effects of 0.1 JAM tamoxifen, are consistent with previous observations in oestrogen unresponsive sub-clones of MCF-7 (Darbre & Daly, 1989; Katzenellenbogen et al., 1987) . It will be necessary to study the effects of bile acids on cell proliferation, as well as on oestrogen-regulated proteins, using different cell lines that are clearly responsive or dependent on oestrogen for growth. These matters apart, our data show that GCDC appears to have a slightly more pronounced effect on the growth of the MCF-7 cells used in the present study than oestradiol. In contrast to the conjugated bile acid, CDC, and possibly other unconjugated bile acids, appears to have either little effect on cell growth or to reduce it, at least at concentrations above 10 JM. The absence of growth stimulation by this bile acid is interesting in view of its effects on ER and regulated proteins and requires further study.
The present study demonstrates that at high concentrations GCDC is cytostatic, and eventually cytotoxic, to MCF-7 human breast cancer cells. The cytostatic/cytotoxic effect of GCDC appears to be related to the capacity of the serum containing medium to bind bile acids thereby limiting its concentration in free solution. Although the serum binding involves low affinity sites which do not affect the bioavailability of the bile acids, the cytostatic/cytotoxic effects of GCDC were only seen at concentrations in excess of the binding capacity of the medium. Thus with medium containing 10% FCS inhibition of cell growth occurred at a higher concentration than with 5% FCS (data not shown). This suggests that bile acids in free solution, even below the critical micellar concentration, interact with the cell differently than when bound to serum proteins and/or lipoproteins. The latter may therefore be involved in bile acid 'uptake' by breast cancer cells.
Apart from the present report and our other preliminary studies (Baker et al., 1991) , the uptake of bile acids by breast cancer cells has not been previously demonstrated. Although bile acid uptake by breast cancer cells seems surprising, there is increasing evidence that bile acids occur in extrahepatic tissues (Dupont et al., 1988) . Bile acids are probably largely transported in the serum via lipoprotein (Dupont et al., 1988) , and a role for lipoproteins in the cellular uptake of bile acids would be consistent with the observation that breast cyst fluid contains high concentrations of nonesterified cholesterol and HDL (Baker, 1990) . The data presented do not indicate whether the bile acids are internalised or bound to the plasma membrane surface. The observation that control cells contained levels of bile acid similar to those incubated with 10 IUM GCDC is consistent with a very slow rate of bile acid uptake from residual bile acid in the experimental medium and/or retention of bile acid taken up from high concentrations in the maintenance medium which contained unstripped FCS. We have observed prolonged retention of fluorescent bile acid analogues by human breast cancer cells including MCF-7 cells and unpublished observation). The relatively low levels of cellassociated bile acid, particularly for cells incubated with 10 JM GCDC, might be expected if bile acids are taken up via lipoproteins into which exogenously added bile acids are not readily incorporated. On the other hand, a high extracellular bile acid concentration may limit the rate of efflux of bile acid already internalised or bound to the cell surface. Incubation of cells with a 5-fold higher concentration of GCDC produced, on average, a 5-fold higher bile acid level in the cell extracts indicating that significant bile acid uptake is dependent on a large concentration gradient. The higher level of bile acid in cells incubated with 10 JAM CDC suggests that unconjugated bile acids enter or bind to the cell, or become incorporated into lipoproteins, more readily than the less hydrophobic glycine conjugates. 
